4527 — Rohto Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Rohto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	72,791	79,951	89,210	77,161	86,816
Net Total Accounts Receivable
Net Total Receivables	51,682	60,656	69,115	69,880	76,847
Total Inventory
Total Other Current Assets
Total Current Assets	164,306	190,246	214,759	217,879	239,274
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62,839	66,182	68,607	90,451	93,011
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	274,876	309,677	346,175	421,875	485,771
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	71,488	80,162	87,087	94,608	117,349
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	96,476	100,107	99,849	161,780	183,943
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	178,400	209,570	246,326	260,095	301,828
Total Liabilities & Shareholders' Equity	274,876	309,677	346,175	421,875	485,771
Total Common Shares Outstanding